Your trusted destination for CME, CPD & Medical Education across the Middle East.
Sultan Qaboos University Hospital
Prof. Dr. Salam Al Kindi is a distinguished Omani clinical hematologist, hemato-oncologist, medical researcher, and academic department leader who has dedicated over twenty-five years to advancing the clinical management, translational research, and therapeutic outcomes for patients suffering from hemoglobinopathies, inherited anemias, bone marrow failure syndromes, and classical hematologic disorders. He earned his Doctor of Medicine (MD) degree with highest academic honors, followed by structured postgraduate residency training in internal medicine and specialized clinical fellowship training in hematology. Committed to achieving international standards of clinical excellence, he completed advanced fellowship certifications, attaining Fellowship of the Royal College of Physicians (FRCP) and Fellowship of the Royal College of Pathologists (FRCPath) in the United Kingdom.
Holding senior academic professorships and clinical consultant appointments at Sultan Qaboos University Hospital in Muscat, Prof. Al Kindi serves as a cornerstone of the Department of Hematology. His specialized clinical scope encompasses the comprehensive care of adult and pediatric patients with severe sickle cell disease, thalassemia major,myelodysplastic syndromes, aplastic anemia, immune thrombocytopenia (ITP), and complex thrombotic and hemostatic disorders, alongside overseeing specialized bone marrow transplantation services.
Throughout his distinguished career in the Sultanate of Oman, Prof. Al Kindi has been a primary visionary in establishing advanced clinical protocols and specialized multidisciplinary care centers for hereditary blood disorders. By introducing evidence-based disease-modifying therapies, chelation regimens, and comprehensive hematopoietic stem cell transplant pathways, he has significantly improved the quality of life, reduced hospitalization rates, and enhanced long-term survival for patients afflicted with severe chronic hematologic conditions.
A central milestone of Prof. Al Kindi’s professional leadership has been championing national screening programs and public health registries for hemoglobinopathies and rare blood disorders across Oman. Working in close collaboration with the Omani Ministry of Health, university researchers, and international hematology societies, his epidemiological initiatives and pre-marital screening guidelines have served as a model for hereditary disease prevention and regional healthcare policy development throughout the Gulf region.
In addition to his demanding clinical schedule and hospital directorship, Prof. Al Kindi is a celebrated university professor, master educator, and clinical mentor. He has trained generations of medical students, internal medicine residents, and clinical hematology fellows who now hold prominent leadership positions across Oman and neighboring GCC nations. His instructional philosophy emphasizes meticulous clinical evaluation, deep understanding of molecular pathophysiology, rigorous adherence to international treatment standards, and compassionate, patient-centered care.
Prof. Al Kindi is an exceptionally prolific physician-scientist who has authored over 120 peer-reviewed scientific publications, clinical trial reports, and book chapters in prestigious international journals, including Blood, British Journal of Haematology, Transfusion, American Journal of Hematology, and Journal of Pediatric Hematology/Oncology. His published research portfolio remains an indispensable reference for hematologists, pathologists, and internal medicine specialists worldwide.
Beyond his university and hospital commitments, Prof. Al Kindi holds prominent executive leadership roles in regional and global professional organizations, including the Oman Society of Hematology (OSH), the Arab Hematology Association, and the International Society on Thrombosis and Haemostasis (ISTH). He routinely represents Oman as an invited keynote speaker, course director, and visiting professor at major international congresses, advocating for equitable access to advanced hematologic therapies, enhanced regional collaboration, and robust clinical research networks.
At the International Classical Hematology Conference 2026 | ICCH 2026, Prof. Dr. Salam Al Kindi stands out as a core scientific keynote presenter, masterclass director, and steering committee leader. Connecting classical hematologists,hemato-oncologists, bone marrow transplant specialists, and laboratory scientists, he provides delegates with crucial,cutting-edge tools to harness advanced therapeutic options, manage complex red blood cell disorders, and elevate classical hematology healthcare standards nationwide and across the region.

MeetingMinds Experts
MeetingMinds Experts

MeetingMinds Experts
MeetingMinds Experts